Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 254 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2927 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-LOSARTAN | 25MG | TABLET | Resolved | 2019-07-02 | 2020-04-23 | 88198 |
| TEVA-LOSARTAN | 50MG | TABLET | Resolved | 2019-07-02 | 2019-11-01 | 88201 |
| TEVA-LOSARTAN | 50MG | TABLET | Resolved | 2019-07-02 | 2019-11-01 | 88204 |
| TEVA-LOSARTAN | 50MG | TABLET | Resolved | 2019-11-21 | 2020-09-03 | 99429 |
| TEVA-LOSARTAN | 100MG | TABLET | Resolved | 2019-11-21 | 2020-04-23 | 99435 |
| TEVA-LOSARTAN | 50MG | TABLET | Resolved | 2019-11-28 | 2020-08-21 | 99959 |
| TEVA-LOSARTAN | 100MG | TABLET | Resolved | 2020-05-01 | 2020-08-21 | 113791 |
| TEVA-LOSARTAN | 25MG | TABLET | Resolved | 2020-05-08 | 2020-08-21 | 114439 |
| TEVA-LOSARTAN | 50MG | TABLET | Resolved | 2021-04-21 | 2024-04-01 | 137899 |
| TEVA-LOSARTAN | 100MG | TABLET | Resolved | 2021-04-21 | 2024-04-01 | 137902 |
| TEVA-LOSARTAN | 25MG | TABLET | Resolved | 2021-04-29 | 2024-04-01 | 138306 |
| TEVA-LOSARTAN | 50MG | TABLET | Resolved | 2021-04-29 | 2021-05-20 | 138309 |
| TEVA-LOSARTAN | 100MG | TABLET | Resolved | 2021-04-29 | 2021-05-20 | 138312 |
| TEVA-LOSARTAN | 25MG | TABLET | Resolved | 2021-05-13 | 2021-05-20 | 139306 |
| TEVA-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Resolved | 2019-07-02 | 2020-06-18 | 88207 |
| TEVA-LOSARTAN/HCTZ | 25MG 100MG | TABLET | Resolved | 2019-07-02 | 2020-06-25 | 88210 |
| TEVA-LOSARTAN/HCTZ | 100MG 12.5MG | TABLET | Resolved | 2020-10-30 | 2021-02-12 | 127622 |
| TEVA-LOSARTAN/HCTZ | 100MG 25MG | TABLET | Resolved | 2020-12-17 | 2021-02-12 | 130319 |
| TEVA-MEDROXYPROGESTERONE | 10MG | TABLET | Resolved | 2017-03-17 | 2017-10-10 | 3130 |
| TEVA-MEDROXYPROGESTERONE | 2.5MG | TABLET | Resolved | 2017-04-03 | 2018-02-21 | 5213 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT ENALAPRIL | 8MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258676 |
| ACT ENALAPRIL | 4MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258682 |
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| ACT ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2019-02-21 | 2019-03-01 | 76486 |
| ACT FLUCONAZOLE | 50MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258697 |
| ACT FLUCONAZOLE | 100MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258703 |
| TEVA-LEVETIRACETAM | 500MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104304 |
| TEVA-LEVOFLOXACIN | 250MG | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266377 |
| TEVA-LEVOFLOXACIN | 500MG | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266380 |
| TEVA-LEVOFLOXACIN | 750MG | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266383 |
| ACT NABILONE | 1MG | CAPSULE | Discontinued | 2019-10-31 | 2019-11-01 | 97581 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2020-10-15 | 2020-10-15 | 126452 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2021-09-23 | 2021-09-23 | 146066 |
| ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
| ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
| TEVA-OLMESARTAN | 20MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117497 |